AI assistant
Comvita Limited — Director's Dealing 2019
Nov 29, 2019
66182_rns_2019-11-29_999ac697-77f2-4da7-8360-8dae96b832d2.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [102 x 28] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests Sections 297(1) and 298(1), Financial Markets Conduct Act 2013
To NZX Limited; and Name of listed issuer: Date this disclosure made: Date of last disclosure: Director or senior manager giving disclosure Full name(s): Name of listed issuer: Name of related body corporate (if applicable): Position held in listed issuer:
Comvita Limited 29/11/2019 30/08/2019 Robert Malcolm Major Comvita Limited n/a Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Class of affected quoted financial products: Ordinary Nature of the affected relevant interest(s): Joint registered holder For that relevant interest- Number held in class before acquisition or disposal: 12,575 Number held in class after acquisition or disposal: 19,375 Current registered holder(s): Registered holder(s) once transfers are registered: Details of transactions giving rise to acquisition or disposal
Ordinary shares Joint registered holder Ms S A Parkinson & Mr R M Major - 12,575 Ms S A Parkinson & Mr R M Major - 19,375 Ms S A Parkinson & Mr R M Major Same as current registered holders 1
Total number of transactions to which notice relates:
Details of transactions requiring disclosure-
| Details of transactions requiring disclosure- | ||
|---|---|---|
| Date oftransaction: | 29/11/2019 | |
| Purchase of 6,800 ordinary shares | ||
| Nature of transaction: | on market | |
| Name ofany otherparty orparties to the transaction(if known): | N/A | |
| The consideration, expressed in New Zealand dollars, paid or received for the | ||
| acquisition or disposal. If the consideration was not in cash and cannot be readily by | $19,720.00 | |
| converted into a cash value,describe the consideration: | ||
| Numberof financialproducts towhichthe transaction related: | 1 | |
| If the issuer has a financial products trading policy that prohibits directors or senior | ||
| managers from trading during any period without written clearance (a closed period) | ||
| include the following details— | ||
| Whether relevantinterestswere acquired ordisposed ofduring a closed period: | No | |
| Whether prior written clearance was provided to allow the acquisition or disposal to | ||
| proceed duringthe closedperiod: | n/a | |
| Date of the prior written clearance (if any): | n/a |
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature:
==> picture [100 x 29] intentionally omitted <==
29/11/2019